Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Immunomedics Inc (NQ: IMMU )

87.86 USD UNCHANGED
Last Price Updated: 7:41 PM EDT, Oct 22, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Immunomedics Inc

< Previous 1 2 3 4 5 6 7 8 9
...
37 38 Next >
Portnoy Law Firm: Tactile Systems Technology, Inc., Pintec Technologies Holdings Limited, and Immunomedics, Inc. Investors Have Limited Amount of Time Before Class Action Deadline
Investors with losses are encouraged to contact Attorney Lesley F. Portnoy. 
From GlobeNewswire News Releases
BioMedNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Board Appointment of Dr. Khalid Islam
From InvestorBrandNetwork
Processa Pharmaceuticals Announces the Appointment of Dr. Khalid Islam to Its Board of Directors
From GlobeNewswire News Releases
Gilead Sciences Completes Acquisition of Immunomedics, Inc.
Gilead Sciences, Inc. (Nasdaq: GILD) today announced the completion of the previously announced transaction to acquire Immunomedics, Inc. (Nasdaq: IMMU) for approximately $21 billion in the aggregate. 
From Business Wire News Releases
ProteoNic Announces Licensing of Technology for Production of Biologics to Immunomedics
ProteoNic BV, a leading provider of technology and services in the field of production of biologics, today announced it has licensed its premium 2G UNic™ technology for boosting therapeutic protein... 
From PR Newswire
Immunomedics Announces FDA Orphan Drug Designation of Trodelvy™ for Adult and Pediatric Glioblastoma
From GlobeNewswire News Releases
ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders are Encouraged to Contact the Firm - CBMG, VRTU, MR, IMMU, JCAP
Halper Sadeh LLP, a global investor rights law firm, is investigating: 
From PR Newswire
WeissLaw LLP Reminds MR, IMMU, and BMCH Shareholders About Its Ongoing Investigations
From PR Newswire
Moore Kuehn Encourages IMMU, MOBL, MR, and SCBH Investors to Contact Law Firm
From GlobeNewswire News Releases
IMPORTANT SHAREHOLDER ALERT: Halper Sadeh LLP Reminds Investors About Its Ongoing Investigations; Shareholders are Encouraged to Contact the Firm – CBMG, RST, IMMU, VAR
From ACCESSWIRE
WeissLaw LLP Reminds MR, IMMU, and BMCH Shareholders About Its Ongoing Investigations
From PR Newswire
SHAREHOLDER ALERT: WeissLaw LLP Reminds AKCA, IMMU, and MXIM Shareholders About Its Ongoing Investigations
From PR Newswire
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of IMMU, VRTU, RST, and CBMG Buyouts
From GlobeNewswire News Releases
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Reminds Investors About Its Ongoing Investigations; Shareholders are Encouraged to Contact the Firm – CBMG, AKCA, VRTU, IMMU
From ACCESSWIRE
(IMMU) Alert: Johnson Fistel Investigates Proposed Sale of Immunomedics; Is $88 a Fair Price?
Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Immunomedics Inc. (NASDAQ: IMMU) ("Immunomedics" or the "Company") breached their... 
From PR Newswire
Immunomedics Announces Positive Results from Pivotal Phase 2 TROPHY U-01 Study of Trodelvy™ in Metastatic Urothelial Cancer
From GlobeNewswire News Releases
Trodelvy™ Significantly Extends Survival in Phase 3 ASCENT Study of Metastatic Triple-Negative Breast Cancer
From GlobeNewswire News Releases
Immunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers
Results include partial responses in small cohort of patients with brain metastasis from breast cancer (BMBC) and recurrent glioblastoma (rGBM) 
From GlobeNewswire News Releases
Lifshitz Law Firm, P.C. Announces Investigation of Immunomedics, Inc. (NASDAQ: IMMU), Livongo Health, Inc. (NASDAQ:LVGO), Varian Medical Systems, Inc. (NYSE: VAR) and Virtusa Corporation (NASDAQ: VRTU
From GlobeNewswire News Releases
Nanomedicine Seen As A Promising Approach For Diagnosis and Treatment Against COVID
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Nanomedicine Seen As A Promising Approach For Diagnosis and Treatment Against COVID
- Financialnewsmedia.com News Commentary 
From PR Newswire
Moore Kuehn Encourages IMMU, ONDK, VRTU, and OTEL Investors to Contact Law Firm
Moore Kuehn, PLLC, a securities litigation law firm located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to... 
From PR Newswire
ALERT: Halper Sadeh LLP Is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm
Halper Sadeh LLP, a global investor rights law firm, is investigating: 
From PR Newswire
SHAREHOLDER ALERT: WeissLaw LLP Investigates Immunomedics, Inc.
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Immunomedics, Inc. ("IMMU" or the "Company") (NASDAQ: IMMU) in connection with... 
From PR Newswire
IMMUNOMEDICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Immunomedics - IMMU
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Immunomedics (NasdaqGS: IMMU) to Gilead... 
From Business Wire News Releases
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Immunomedics, Inc. Buyout
From GlobeNewswire News Releases
Thinking about trading options or stock in Immunomedics, Oracle, Vir Biotechnology, United Airlines, or Tesla?
InvestorsObserver issues critical PriceWatch Alerts for IMMU, ORCL, VIR, UAL, and TSLA. 
From PR Newswire
Immunomedics Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Immunomedics, Inc. is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – IMMU
Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Immunomedics, Inc. (NASDAQ: IMMU) to Gilead Sciences, Inc. for $88.00 per share is fair to Immunomedics... 
From Business Wire News Releases
Gilead Sciences to Acquire Immunomedics
Gilead Sciences, Inc. (Nasdaq: GILD) and Immunomedics (Nasdaq: IMMU) announced today that the companies have entered into a definitive agreement pursuant to which Gilead will acquire Immunomedics for... 
From Business Wire News Releases
Immunomedics Announces Key Oral Presentations at ESMO Virtual Congress 2020
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
37 38 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.